SIMC yields 2000000.00% · JNJ yields 2.14%● Live data
📍 SIMC pulled ahead of the other in Year 1
Combined, SIMC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SIMC + JNJ for your $10,000?
Simclar, Inc., together with its subsidiaries, operates as a contract manufacturer of electronic and electro-mechanical products in the United States and Mexico. Its custom-designed products include complex printed circuit boards (PCBs), finished products, subassemblies, molded and nonmolded cable assemblies, wire harnesses, injection molded, and electronic assembly products. The PCBs produced by the company comprise pin-through-hole assemblies, low and medium volume surface mount technology assemblies, and mixed technology PCBs, including multilayer PCBs; and cable and harness assemblies consist of multiconductor, ribbon, coaxial cable, and discrete wire harness assemblies. The company also provides contract manufacturing services, which involves the manufacture of complete finished assemblies with all sheet metal, power supplies, fans, and PCBs, as well as complete sub-assemblies for integration into original equipment manufactures (OEMs) finished products, such as speaker and lock-key assemblies, and diode assemblies. In addition, Simclar offers reworking and refurbishing services, which comprise redesign, rework, refurbish, and repair of materials and subassemblies; sheet metal fabrication services; and backplane interconnect solutions. The company's products are manufactured to customer specifications and designed for OEMs in the data processing, telecommunications, instrumentation, and food preparation equipment industries. The company was formerly known as Techdyne, Inc. and changed its name to Simclar, Inc. in September 2003. The company was founded in 1976 and is based in Hialeah, Florida. Simclar, Inc. operates as a subsidiary of Simclar Group Limited.
Full SIMC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.